Exp Clin Endocrinol Diabetes 2006; 114(1): 28-30
DOI: 10.1055/s-2005-865927
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Thyrotoxicosis-induced Prinzmetal Variant Angina

V. Pavlicek1 , 2 , H. Zeif2 , F. Widmer2
  • 1Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zürich, Switzerland
  • 2Department of Medicine, Division of Cardiology, Kantonsspital Münsterlingen, Switzerland
Further Information

Publication History

Received: March 18, 2005 First decision: July 8, 2005

Accepted: July 15, 2005

Publication Date:
01 February 2006 (online)

Abstract

We describe a postmenopausal women with new onset of variant angina caused by thyrotoxicosis due to Graves' disease. During exercise bicycle ergometry at 50 Watts, the patient developed typical angina with ST segment elevation in the precordial leads. A coronary angiogram revealed normal coronary arteries. Graves' disease with overt hyperthyroidism was diagnosed. After achieving an euthyroid state with administration of propylthiouracil, the symptoms resolved completely and the patient had a normal exercise capacity without electrocardiographic changes. Thus, we conclude that in patients with thyrotoxicosis, variant angina and normal coronary arteries, restoration of normal thyroid function may be curative.

References

  • 1 Boccalandro C, Lopez-Penabad L, Boccalandro F, Lavis V. Ventricular fibrillation in a young Asian man.  Lancet. 2003;  361 1432
  • 2 Emdin M, Pratali L, Iervasi G. Abolished vagal tone associated with thyrotoxicosis triggers Prinzmetal variant angina and paroxysmal atrial fibrillation.  Ann Intern Med. 2000;  132 679
  • 3 Featherstone H J, Stewart D K. Angina in thyrotoxicosis. Thyroid-related coronary artery spasm.  Arch Intern Med. 1983;  143 554-555
  • 4 Glikson M, Freimark D, Leor R, Shechter M, Kaplinsky E, Rabinowitz B. Unstable angina syndrome and pulmonary edema due to thyrotoxicosis.  Postgrad Med J. 1991;  76 81-83
  • 5 Kawano H, Motoyama T, Hirai N, Kugiyama K, Ogawa H, Yasue H. Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina.  J Am Coll Cardiol. 2001;  37 735-740
  • 6 Mang G, Schuiki E, Amann F W. Hyperventilation test: a noninvasive screening test for coronary vasospasm.  Schweiz Med Wochenschr. 1995;  125 777-785
  • 7 Morelli S, Gurgo A M, Martocchia A, Falaschi P. Thyrotoxicosis, unstable angina and normal coronary angiogram.  G Ital Cardiol. 1999;  29 1327-1330
  • 8 Nakano T, Konishi T, Takezawa H. Vasospastic angina in thyrotoxicosis.  Angiology. 1987;  38 717-722
  • 9 Phull P S, Collins C E, Norell M S, Thomas D J. Variant angina in thyrotoxicosis.  Br J Clin Pract. 1993;  47 17
  • 10 Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. 1. A variant form of angina pectoris.  Am J Med. 1959;  27 375-388
  • 11 Proskey A J, Saksena F, Towne W D. Myocardial infarction associated with thyrotoxicosis.  Chest. 1977;  72 109-111
  • 12 Tumurkaynak T, Aydogdu G, Cengel A. Actue myocardial infarction secondary to thyrotoxicosis.  Acta Cardiol. 2002;  57 439-442
  • 13 Wei J Y, Genecin A, Greene H L, Achuff S C. Coronary spasm with ventricular fibrillation during thyrotoxicosis.  Am J Cardiol. 1979;  43 335-339

M.D. Vojtech Pavlicek

Department of Internal Medicine
Division of Endocrinology and Diabetes
University Hospital of Zurich

8091 Zurich

Switzerland

Phone: + 4112551111

Fax: + 41 12 55 44 47

Email: vojtech.pavlicek@usz.ch

    >